Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Initiation and promotion at different ages and doses in 2200 mice. III. Linear extrapolation from high doses may underestimate low-dose tumour risks.

Stenbäck F. et al, (1981), Br J Cancer, 44, 24 - 34

Initiation and promotion at different ages and doses in 2200 mice. I. Methods, and the apparent persistence of initiated cells.

Stenbäck F. et al, (1981), Br J Cancer, 44, 1 - 14

Initiation and promotion at different ages and doses in 2200 mice. II. Decrease in promotion by TPA with ageing.

Stenbäck F. et al, (1981), Br J Cancer, 44, 15 - 23

The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today.

Doll R. and Peto R., (1981), J Natl Cancer Inst, 66, 1191 - 1308

Pentoxifylline for transient ischaemic attacks.

Warlow C. and Peto R., (1981), Lancet, 1, 1103 - 1104

Aspirin and the stomach.

Langston HH., (1981), Br Med J (Clin Res Ed), 282

Can dietary beta-carotene materially reduce human cancer rates?

Peto R. et al, (1981), Nature, 290, 201 - 208

Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study.

(1981), Lancet, 1, 541 - 546

Comparison of cause of death coding on death certificates with coding in the Royal College of General Practitioners Oral Contraception Study.

Wingrave SJ. et al, (1981), J Epidemiol Community Health, 35, 51 - 58

ASPIRIN AND THE STOMACH - REPLY

DOLL R. and PETO R., (1981), BRITISH MEDICAL JOURNAL, 282, 1157 - 1157

Early intravenous atenolol treatment in suspected acute myocardial infarction.

Sleight P. et al, (1981), Acta Med Scand Suppl, 651, 185 - 192

IS THE INCIDENCE OF MULTIPLE-MYELOMA REALLY INCREASING

VELEZ R. et al, (1981), CLINICAL RESEARCH, 29, A261 - A261

NEED FOR LARGE (BUT SIMPLE) TRIALS

PETO R. and YUSUF S., (1981), THROMBOSIS AND HAEMOSTASIS, 46, 325 - 325

Reduction in infarct size and morbidity by early intravenous betablockade

Yusuf S. et al, (1981), American Journal of Cardiology, 47

Menopausal oestrogen use and breast cancer.

Beral V., (1980), Br Med J, 281

Prognostic features in the third MRC myelomatosis trial. Medical Research Council's Working Party on Leukaemia in Adults.

(1980), Br J Cancer, 42, 831 - 840

Report on the second myelomatosis trial after five years of follow-up. Medical Research Council's Working Party on Leukaemia in Adults.

(1980), Br J Cancer, 42, 813 - 822

The epidemiology of ovarian cancer

Beral V., (1980), Advances in the Biosciences, 26, 29 - 38

Treatment comparisons in the third MRC myelomatosis trial. Medical Research Council's Working Party on Leukaemia in Adults.

(1980), Br J Cancer, 42, 823 - 830

Randomised trial of high doses of stilboestrol and ethisterone in pregnancy: long-term follow-up of mothers.

Beral V. and Colwell L., (1980), Br Med J, 281, 1098 - 1101

«
...
68
69
70
71
72
73
74
...
»